Cargando...
Personalized one-two punches for lung cancer
Discovery of individualized therapies to address resistance to tyrosine kinase inhibitors (TKIs) has been hampered by the inability to test drug combinations on patient samples before and after TKI resistance. A recent study published in Science by Crystal et al. describes a methodology for pharmaco...
Guardado en:
Publicado en: | Cell Res |
---|---|
Autores principales: | , , |
Formato: | Artigo |
Lenguaje: | Inglês |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4349242/ https://ncbi.nlm.nih.gov/pubmed/25547118 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2014.168 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|